论文部分内容阅读
目的:对西医内科治疗方法治疗糖尿病的临床效果进行观察与探讨。方法:选取2012年8月至2014年12月中铁港航局三公司医院120例糖尿病患者,以随机数字表为原则分为2组,对照组患者采用二甲双胍治疗,研究组患者采用吡格列酮治疗,分析两组糖尿病患者的疗效。结果:糖尿病患者中,研究组总有效率(93.33%)明显高于对照组(81.67%),差异具有统计学意义(P<0.05);治疗后研究组患者的空腹血糖水平和餐后2 h血糖水平分别为(7.10±1.14)mmol·L-1和(10.18±1.12)mmol·L-1,均明显低于对照组患者的(8.13±1.25)mmol·L-1和(15.67±1.36)mmol·L-1,差异具有统计学意义(P<0.05);研究组患者的复发率(1.67%)明显低于对照组患者(11.67%),差异具有统计学意义(P<0.05)。结论:对糖尿病患者给予吡格列酮治疗的效果明显优于二甲双胍治疗。
Objective: To observe and discuss the clinical effect of Western medicine treatment of diabetes mellitus. Methods: From August 2012 to December 2014, 120 patients with diabetes mellitus from the three hospitals of China National Harbor Shipping Administration were divided into two groups according to the principle of random number table. The patients in the control group were treated with metformin. The patients in the study group were treated with pioglitazone. Efficacy of two groups of diabetic patients. Results: The total effective rate (93.33%) in the study group was significantly higher than that in the control group (81.67%), the difference was statistically significant (P <0.05). After treatment, the fasting blood glucose level and postprandial 2 h (7.10 ± 1.14) mmol·L-1 and (10.18 ± 1.12) mmol·L-1, respectively, were significantly lower than those in the control group (8.13 ± 1.25) mmol·L-1 and (15.67 ± 1.36) The difference was statistically significant (P <0.05). The recurrence rate (1.67%) in the study group was significantly lower than that in the control group (11.67%), the difference was statistically significant (P <0.05). Conclusion: The effect of pioglitazone on diabetic patients is better than that of metformin.